Published in Tissue Eng on July 01, 2006
The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials (2010) 1.14
Extraction and assembly of tissue-derived gels for cell culture and tissue engineering. Tissue Eng Part C Methods (2009) 1.09
Vascularized adipose tissue grafts from human mesenchymal stem cells with bioactive cues and microchannel conduits. Tissue Eng (2007) 1.07
Diffusion and perfusion: the keys to fat grafting. Plast Reconstr Surg Glob Open (2014) 0.92
Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med (2010) 0.88
Animal models for adipose tissue engineering. Tissue Eng Part B Rev (2008) 0.87
An adipoinductive role of inflammation in adipose tissue engineering: key factors in the early development of engineered soft tissues. Stem Cells Dev (2013) 0.85
Macrophages play a key role in angiogenesis and adipogenesis in a mouse tissue engineering model. Tissue Eng Part A (2013) 0.78
Fate of Free Fat Dermis Graft in TMJ Interpositional Gap Arthroplasty: A Long Term MRI Study. J Maxillofac Oral Surg (2014) 0.75
Effect of external volume expansion on the survival of fat grafts. Indian J Plast Surg (2016) 0.75
Adipose Tissue Formation Utilizing Fat Flap Distraction Technique. Sci Rep (2017) 0.75
The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol (2006) 11.16
Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. J Cell Physiol (2007) 7.34
The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res (2005) 3.65
Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo. Cells Tissues Organs (2007) 3.12
Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res (2006) 3.12
Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs (2007) 2.59
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia (2010) 2.38
Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev (2012) 2.08
Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res (2009) 2.05
Nipple sensation losses in Hall-Findlay breast reduction technique. Plast Reconstr Surg (2013) 1.98
Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol (2007) 1.97
Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia (2010) 1.73
Tissue-engineered breast reconstruction: bridging the gap toward large-volume tissue engineering in humans. Plast Reconstr Surg (2011) 1.63
Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer (2007) 1.63
Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. J Cell Biochem (2011) 1.60
Functional impairment after latissimus dorsi flap. ANZ J Surg (2009) 1.55
Coexisting harlequin and Horner syndromes after paediatric neck dissection: a case report and a review of the literature. J Plast Reconstr Aesthet Surg (2007) 1.52
Cardiac tissue engineering in an in vivo vascularized chamber. Circulation (2007) 1.48
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res (2005) 1.45
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Mol Med (2012) 1.41
First hand transplant procedure in Australia: outcome at 2 years. Med J Aust (2013) 1.40
Long-term persistence of tissue-engineered adipose flaps in a murine model to 1 year: an update. Plast Reconstr Surg (2009) 1.39
Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors. Breast Cancer Res (2007) 1.33
Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS One (2012) 1.31
An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J (2006) 1.30
Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin Exp Metastasis (2004) 1.29
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer (2013) 1.27
Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J Cell Mol Med (2010) 1.27
Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res (2004) 1.21
Defining the E-cadherin repressor interactome in epithelial-mesenchymal transition: the PMC42 model as a case study. Cells Tissues Organs (2010) 1.21
Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. Lab Invest (2003) 1.21
Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance. Cancer Lett (2013) 1.18
Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet (2009) 1.17
Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. Am J Pathol (2007) 1.17
Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res (2005) 1.15
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell (2013) 1.14
PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma. BMC Cancer (2006) 1.11
Tissue engineering skin flaps: which vascular carrier, arteriovenous shunt loop or arteriovenous bundle, has more potential for angiogenesis and tissue generation? Plast Reconstr Surg (2003) 1.10
Aberrant fibroblast growth factor receptor signaling in bladder and other cancers. Differentiation (2007) 1.08
Mechanisms of tumour invasion and metastasis: emerging targets for therapy. Expert Opin Ther Targets (2002) 1.06
Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Int J Cancer (2005) 1.05
Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix. Tissue Eng (2006) 1.05
New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials. Plast Reconstr Surg (2004) 1.04
Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition. Breast Cancer Res Treat (2002) 1.04
Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2. Cancer Res (2008) 1.04
Engineering cardiac tissue in vivo from human adipose-derived stem cells. Biomaterials (2010) 1.02
Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro. Biomaterials (2007) 1.01
Type I collagen abrogates the clathrin-mediated internalization of membrane type 1 matrix metalloproteinase (MT1-MMP) via the MT1-MMP hemopexin domain. J Biol Chem (2005) 1.01
Adipose-derived stem cells promote angiogenesis and tissue formation for in vivo tissue engineering. Tissue Eng Part A (2013) 1.01
Increasing the volume of vascularized tissue formation in engineered constructs: an experimental study in rats. Plast Reconstr Surg (2003) 1.01
Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice. Cancer Res (2004) 1.01
Substrate choice of membrane-type 1 matrix metalloproteinase is dictated by tissue inhibitor of metalloproteinase-2 levels. Cancer Sci (2007) 1.01
Vascularized tissue engineering mouse chamber model supports thymopoiesis of ectopic thymus tissue grafts. Tissue Eng Part C Methods (2010) 1.00
Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clin Exp Metastasis (2004) 1.00
Facial infiltrative lipomatosis. Pediatr Radiol (2006) 0.98
Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth. Differentiation (2005) 0.98
Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells. Breast Cancer Res (2013) 0.96
Generation of a vascularized organoid using skeletal muscle as the inductive source. FASEB J (2005) 0.96
Cancer: The to and fro of tumour spread. Nature (2013) 0.96
A systematic review of questionnaires to measure the impact of appearance on quality of life for head and neck cancer patients. J Plast Reconstr Aesthet Surg (2013) 0.95
Reversible transdifferentiation of blood vascular endothelial cells to a lymphatic-like phenotype in vitro. J Cell Sci (2010) 0.95
Time course analysis of hypoxia, granulation tissue and blood vessel growth, and remodeling in healing rat cutaneous incisional primary intention wounds. Wound Repair Regen (2006) 0.95
Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis (2005) 0.94
The influence of architecture on degradation and tissue ingrowth into three-dimensional poly(lactic-co-glycolic acid) scaffolds in vitro and in vivo. Biomaterials (2006) 0.93
Survival and differentiation of pituitary colony-forming cells in vivo. Stem Cells (2007) 0.93
An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer. PLoS One (2012) 0.93
Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer. Int J Biochem Cell Biol (2005) 0.93
Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity. Obesity (Silver Spring) (2007) 0.92
Skin graft failure is predicted by waist-hip ratio: a marker for metabolic syndrome. ANZ J Surg (2007) 0.91
Seeding of pancreatic islets into prevascularized tissue engineering chambers. Tissue Eng Part A (2009) 0.91
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden. BMC Cancer (2014) 0.91
Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines. BMC Cancer (2004) 0.90
The cervico-submental keystone island flap for locoregional head and neck reconstruction. J Plast Reconstr Aesthet Surg (2012) 0.90
Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism. FEBS Lett (2003) 0.90
Host rather than graft origin of Matrigel-induced adipose tissue in the murine tissue-engineering chamber. Tissue Eng (2007) 0.90
Retrograde axonal tracing using manganese enhanced magnetic resonance imaging. Neuroimage (2010) 0.90
Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells. PLoS One (2011) 0.90
Post-traumatic pseudolipomas--a review and postulated mechanisms of their development. J Plast Reconstr Aesthet Surg (2009) 0.90
In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts. BMC Cancer (2006) 0.89
The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells. Matrix Biol (2006) 0.89
Spontaneous large volume adipose tissue generation from a vascularized pedicled fat flap inside a chamber space. Tissue Eng (2007) 0.89
Implanted myoblast survival is dependent on the degree of vascularization in a novel delayed implantation/prevascularization tissue engineering model. Tissue Eng Part A (2010) 0.89
Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue. Breast Cancer Res Treat (2011) 0.89
Seat belt injury to the female breast: review and discussion of its surgical management. ANZ J Surg (2010) 0.89
Prefabricated engineered skin flap using an arteriovenous vascular bundle as a vascular carrier in rabbits. Plast Reconstr Surg (2006) 0.88